Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 57

Sort by

Sort Order Select

Journal Articles

FLAG-IDA as frontline induction improves outcomes in pediatric patients with core-binding factor or KMT2A-rearranged acute myeloid leukemia: A multicenter cohort study in southern China

Blood (2025) 146 (Supplement 1): 5152.

https://doi.org/10.1182/blood-2025-5152

Published: 2025

Journal Articles

Low-dose chemotherapy for induction in pediatric AML: Retrospective outcome analysis across expanded cohorts

Blood (2025) 146 (Supplement 1): 1661.

https://doi.org/10.1182/blood-2025-1661

Published: 2025

Journal Articles

High fructose diet exacerbates acute GVHD through microbiota dysbiosis and HIF-1α–mediated macrophage activation

Kunpeng Wu, Huihui Yu, Kankan Cao, Bo Dai, Hua Jiang, Tong Chen

Blood (2025) 146 (Supplement 1): 4082.

https://doi.org/10.1182/blood-2025-4082

Published: 2025

Journal Articles

Multicenter prospective Phase II study of decitabine priming combined with low-dose idarubicin, cytarabine, and G-CSF in children with refractory or relapsed Acute Myeloid Leukemia

Blood (2025) 146 (Supplement 1): 5233.

https://doi.org/10.1182/blood-2025-5233

Published: 2025

Journal Articles

Molecular risk stratification and MRD-guided consolidation determine outcomes in pediatric non-down syndrome acute megakaryoblastic leukemia: A multicentre Chinese cohort study

Yongzhi Zheng, Chunxia Cai, Yiqiao Chen, Xiaoqin Feng, Chunfu Li, Mincui Zheng, Huirong Mai, Lihua Yang, Hua Jiang, Xiangling He, Hong Wen, Honggui Xu, Nainong Li, Shaohua Le

Blood (2025) 146 (Supplement 1): 5291.

https://doi.org/10.1182/blood-2025-5291

Published: 2025

Journal Articles

Allogeneic hematopoietic stem cell transplantation for transfusion-dependent pyruvate kinase deficiency in Chinese children: A multicenter retrospective study

Xia Qin, Jing Chen, Rong Liu, Kai Chen, Yunyan He, Sun Yuan, Xiaodong Wang, Ke Huang, Guanghua Zhu, Xiaofan Zhu, Shaoyan Hu, Hua Jiang, Xiaojun Xu, Yiping Zhu

Blood (2025) 146 (Supplement 1): 2521.

https://doi.org/10.1182/blood-2025-2521

Published: 2025

Journal Articles

Blinatumomab following reduced-intensity induction chemotherapy in Chinese children with intermediate- or high-risk B-cell precursor acute lymphoblastic leukemia

Blood (2025) 146 (Supplement 1): 5133.

https://doi.org/10.1182/blood-2025-5133

Published: 2025

Journal Articles

Prognostic and therapeutic implications of measurable residual disease levels during remission induction of childhood ALL

Blood (2025) 145 (17): 1890–1902.

https://doi.org/10.1182/blood.2024026381

Published: 2025

Includes: Supplemental data

Journal Articles

Male Sex Had an Adverse Impact on Outcomes of Pediatric B-Lineage Acute Lymphoblastic Leukemia

Blood (2024) 144 (Supplement 1): 5868.

https://doi.org/10.1182/blood-2024-210903

Published: 2024

Journal Articles

Outcomes of Children and Adolescents with Acute Myeloid Leukemia and KIT Mutations Treated with Low- or Standard-Dose Chemotherapy Plus Dasatinib on the CALSⅢ-AML18 Trial

Yixin Hu, Xiuli Ju, Yunyan He, Ningling Wang, Xiaowen Zhai, Yufeng Liu, Hua Jiang, Hongjun Liu, Liangchun Yang, Minghua Yang, Jixia Luo, Qi An, Xiaojun Yuan, Qian-Fei Wang, Raul C. Ribeiro, Shaoyan Hu

Blood (2024) 144 (Supplement 1): 6050.

https://doi.org/10.1182/blood-2024-211911

Published: 2024

Journal Articles

Outcomes of Children and Adolescents with Acute Myeloid Leukemia and FLT3-ITD Treated with Low- or Standard-Dose Chemotherapy Plus Sorafenib on the Cals III-AML18 Trial (ChiCTR1800015883)

Li Gao, Hua Jiang, Xiuli Ju, Yunyan He, Hongjun Liu, Xiaowen Zhai, Ningling Wang, Minghua Yang, Jixia Luo, Yufeng Liu, Liangchun Yang, Qi An, Xiaojun Yuan, Qian-Fei Wang, Raul C. Ribeiro, Shaoyan Hu

Blood (2024) 144 (Supplement 1): 6049.

https://doi.org/10.1182/blood-2024-211113

Published: 2024

Journal Articles

A First-in-Human Study of CT0590, a Triple Knock-out, Allogeneic CAR T-Cell Therapy Targeting BCMA and NKG2A, in Subjects with Relapsed/Refractory Multiple Myeloma

Chengcheng Fu, Lingzhi Yan, Weiqin Yao, Jingjing Shang, Song Jin, Shuang Yan, Fang Tang, Ziling Zhu, Depei Wu, Ying Li, Nishanthan Rajakumaraswamy, Wei Zheng, Hua Jiang, Zhaohui Liao, Zonghai Li

Blood (2024) 144 (Supplement 1): 4843.

https://doi.org/10.1182/blood-2024-204401

Published: 2024

Journal Articles

A Prospective Investigator-Initiated Phase 1/2 Study of BCMA/CD19 Dual-Targeting CAR T Therapy in Patients with Relapsed/Refractory Multiple Myeloma Including Those with Extramedullary Disease

Hua Jiang, Lu Li, Kaili Chen, Chunchen Yang, Ruixue Ma, Liangyu Xie, Can He, Fang Feng, Hao Wu, Xiaomei Chen, Dan Li, Xianghai Cai, Jin Zhao, Tao Guan, Li Ma, Min Bai, Guoxiang Wu, Liping Su, Weijun Fu

Blood (2024) 144 (Supplement 1): 923.

https://doi.org/10.1182/blood-2024-201160

Published: 2024

Journal Articles

The Efficacy and Safety of Huaiqihuang Granules in the Treatment of Childhood Chronic Primary Immune Thrombocytopenia: A Multicentre, Randomized, Double-Blind, Placebo-Controlled Clinical Study

Juan Han, Fen Zhou, Runming Jin, Xiaodong Shi, Jianxin Li, Yongjun Fang, Xiaojun Yuan, Xuequn Luo, Jianqin Li, Lirong Sun, Wenjun Liu, Mei Yan, Yufeng Liu, Changda Liang, Hua Jiang, Runhui Wu

Blood (2024) 144 (Supplement 1): 5461.

https://doi.org/10.1182/blood-2024-210064

Published: 2024

Journal Articles

Outcomes of Children and Adolescents with Acute Myeloid Leukemia Given a Low-Versus Standard-Dose Chemotherapy Regimen for Remission Induction (CALSIII-AML18): A Multicenter, Phase 3, Randomized, Noninferiority Trial

Blood (2023) 142 (Supplement 1): 729.

https://doi.org/10.1182/blood-2023-189253

Published: 2023

Journal Articles

A Multicenter Clinical Study with Reduced Intensive Chemotherapy for Induction Remission of Pediatric Acute Megakaryoblastic Leukemia

Blood (2023) 142 (Supplement 1): 4276.

https://doi.org/10.1182/blood-2023-190821

Published: 2023

Journal Articles

Decitabine Combined with Low-Dose Chemotherapy Is Effective in the Treatment of Pediatric Refractory/Relapsed Acute Myeloid Leukemia

Liyan Fan, Hua Jiang, Hongjun Liu, Ning Liao, Ningling Wang, Xiaowen Zhai, Xiuli Ju, Yufeng Liu, Jixia Luo, Peifang Xiao, Jun Lu, Hailong He, Yi Wang, Raul C. Ribeiro, Shaoyan Hu

Blood (2023) 142 (Supplement 1): 2905.

https://doi.org/10.1182/blood-2023-191115

Published: 2023

Journal Articles

Single Cell Analysis Identifies Immune Marker IL4I1 As Critical for Leukemogenesis and Immunity

Denggang Fu, Hua Jiang, Sophie Paczesny

Blood (2022) 140 (Supplement 1): 8582–8583.

https://doi.org/10.1182/blood-2022-167399

Published: 2022

Journal Articles

Novel Chemical Series of Anti-ST2 Small Molecules Suppress Allogeneic T Cells Proliferation While Increasing Treg Cells and Improve Gvhd and Survival In Vivo

Chao-Yie Yang, Xinrui Yuan, Hua Jiang, Jason C. Rech, Denggang Fu, Aaron Robida, Krishani Rajanayake, Hebao Yuan, Bo Wen, Duxin Sun, Krishnapriya Chinnaswamy, Jeanne A. Stuckey, Sophie Paczesny

Blood (2022) 140 (Supplement 1): 10675–10677.

https://doi.org/10.1182/blood-2022-163374

Published: 2022

Journal Articles

Genetic Variation and Survival Analysis of Childhood AML By C-Huanan AML 2015 Protocol in China:Multicenter Clinical Study in 546 Cases

Xiaoqin Feng, Chunfu Li, Jian Li, Mincui Zheng, Sixi Liu, Lihua Yang, Hua Jiang, Honggui Xu, Hong Wen, Xiangling He

Blood (2022) 140 (Supplement 1): 6090–6091.

https://doi.org/10.1182/blood-2022-169458

Published: 2022

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

FLAG-IDA as frontline induction improves outcomes in pediatric patients with core-binding factor or KMT2A-rearranged acute myeloid leukemia: A multicenter cohort study in southern China

Low-dose chemotherapy for induction in pediatric AML: Retrospective outcome analysis across expanded cohorts

High fructose diet exacerbates acute GVHD through microbiota dysbiosis and HIF-1α–mediated macrophage activation

Multicenter prospective Phase II study of decitabine priming combined with low-dose idarubicin, cytarabine, and G-CSF in children with refractory or relapsed Acute Myeloid Leukemia

Molecular risk stratification and MRD-guided consolidation determine outcomes in pediatric non-down syndrome acute megakaryoblastic leukemia: A multicentre Chinese cohort study

Allogeneic hematopoietic stem cell transplantation for transfusion-dependent pyruvate kinase deficiency in Chinese children: A multicenter retrospective study

Blinatumomab following reduced-intensity induction chemotherapy in Chinese children with intermediate- or high-risk B-cell precursor acute lymphoblastic leukemia

Prognostic and therapeutic implications of measurable residual disease levels during remission induction of childhood ALL

Male Sex Had an Adverse Impact on Outcomes of Pediatric B-Lineage Acute Lymphoblastic Leukemia

Outcomes of Children and Adolescents with Acute Myeloid Leukemia and KIT Mutations Treated with Low- or Standard-Dose Chemotherapy Plus Dasatinib on the CALSⅢ-AML18 Trial

Outcomes of Children and Adolescents with Acute Myeloid Leukemia and FLT3-ITD Treated with Low- or Standard-Dose Chemotherapy Plus Sorafenib on the Cals III-AML18 Trial (ChiCTR1800015883)

A First-in-Human Study of CT0590, a Triple Knock-out, Allogeneic CAR T-Cell Therapy Targeting BCMA and NKG2A, in Subjects with Relapsed/Refractory Multiple Myeloma

A Prospective Investigator-Initiated Phase 1/2 Study of BCMA/CD19 Dual-Targeting CAR T Therapy in Patients with Relapsed/Refractory Multiple Myeloma Including Those with Extramedullary Disease

The Efficacy and Safety of Huaiqihuang Granules in the Treatment of Childhood Chronic Primary Immune Thrombocytopenia: A Multicentre, Randomized, Double-Blind, Placebo-Controlled Clinical Study

Outcomes of Children and Adolescents with Acute Myeloid Leukemia Given a Low-Versus Standard-Dose Chemotherapy Regimen for Remission Induction (CALSIII-AML18): A Multicenter, Phase 3, Randomized, Noninferiority Trial

A Multicenter Clinical Study with Reduced Intensive Chemotherapy for Induction Remission of Pediatric Acute Megakaryoblastic Leukemia

Decitabine Combined with Low-Dose Chemotherapy Is Effective in the Treatment of Pediatric Refractory/Relapsed Acute Myeloid Leukemia

Single Cell Analysis Identifies Immune Marker IL4I1 As Critical for Leukemogenesis and Immunity

Novel Chemical Series of Anti-ST2 Small Molecules Suppress Allogeneic T Cells Proliferation While Increasing Treg Cells and Improve Gvhd and Survival In Vivo

Genetic Variation and Survival Analysis of Childhood AML By C-Huanan AML 2015 Protocol in China:Multicenter Clinical Study in 546 Cases

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only